Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.37 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16360618 | 0.80 | — | — | |
| SCHEMBL14718622 | 0.80 | — | — | |
| SCHEMBL4427482 | 0.78 | CYP3A4 (0.37) | CYP3A4TSHRMAPTCACNA1BAPBA1 | |
| SCHEMBL4434217 | 0.78 | CYP3A4 (0.37) | CYP3A4TSHRMAPTCACNA1BAPBA1 | |
| SCHEMBL9435890 | 0.78 | CYP3A4 (0.48) | CYP3A4TSHRMAPTCACNA1BAPBA1 | |
| SCHEMBL14214710 | 0.77 | CYP3A4 (0.36) | CYP3A4TSHRMAPTCACNA1BAPBA1 | |
| SCHEMBL8650930 | 0.74 | — | — | |
| SCHEMBL6697363 | 0.74 | CYP3A4 (0.33) | CYP3A4TSHRMAPTCACNA1BAPBA1 | |
| SCHEMBL14719798 | 0.74 | — | — | |
| SCHEMBL6429741 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462793-A | Glycosylation and alkylation method with participation of benzoiodooxavaleryl reagent | 华中科技大学 | 2025-02-18 | — | — | CN | claimed |
| US-20070191288-A1 | Treatments for Benign Tumors, Cancers, Neoplasias, and/or Other Inflammatory Disorders or Diseases | SHAPIRA NATHAN A | 2007-08-16 | — | — | US | claimed |
| EP-0896972-B1 | METHOD FOR PRODUCING A SELENIZED TRANSPARENT OPTICAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2006-11-29 | — | — | EP | claimed |
| US-20040191310-A1 | Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2004-09-30 | — | — | US | claimed |
| WO-2004050081-A1 | TREATMENTS FOR BENIGN TUMORS, CANCERS, NEOPLASIAS, AND/OR OTHER INFLAMMATORY DISORDERS OR DISEASES | UNIVERSITY OF FLORIDA (US) | 2004-06-17 | — | — | WO | claimed |
| EP-1345602-A2 | TREATMENTS FOR NEUROGENETIC DISORDERS, IMPULSE CONTROL DISORDERS, AND WOUND HEALING | UNIVERSITY OF FLORIDA (US) | 2003-09-24 | — | — | EP | claimed |
| US-20030166830-A1 | Selenium-containing transparent optical material | OKAZAKI KOJU (JP) | 2003-09-04 | — | — | US | claimed |
| US-20030149021-A1 | Piperazine mono(dithio)carbamate ester compounds and analogs thereof: preparation method and uses thereof | MEDINOX, INC. | 2003-08-07 | — | — | US | claimed |
| WO-2002096869-A2 | PIPERAZINE MONO(DITHIO)CARBAMATE ESTER COMPOUNDS AND ANALOGS THEREOF | PEKING UNIVERSITY SCHOOL OF PHARMACEUTICAL SCIENCES (CN) | 2002-12-05 | — | — | WO | claimed |
| US-6482918-B2 | HIGH REFRACTIVE INDEX, LOW DISPERSION AND EXCELLENT OPTICAL PROPERTY, AND IS USED FOR A GLASSES LENS, CAMERA LENS, PRISM, SUBSTRATE FOR AN INFORMATION RECORDING MEDIUM, PICK UP LENS, OPTICAL FIBER, OPTICAL FILTER | MITSUI CHEMICALS, INC. (JP) | 2002-11-19 | — | — | US | claimed |
| US-5384327-A | Anticonvulsant sorbopyranose sulfamates | MCNEILAB, INC. (US) | 1995-01-24 | — | — | US | claimed |
| WO-1994014827-A1 | ANTICONVULSANT SORBOPYRANOSE SULFAMATES | MCNEILAB, INC. (US) | 1994-07-07 | — | — | WO | claimed |
| US-5089116-A | For sulfide minerals | ESTABLECIMIENTOS INDUSTRIALES QUIMICOS OXIQUIM S.A. (CL) | 1992-02-18 | — | — | US | claimed |
| US-4886595-A | RECOVEY OF SULFIDES | ESTABLECIMIENTOS INDUSTRALES QUIMICOS OXIQUIM S.A. (CL) | 1989-12-12 | — | — | US | claimed |
| US-4822483-A | DIAMINE OR AMIDE AND THIOCARBONATE, THIOCARBAMATE, THIOPHOSPHATE, MERCAPTAN, XANTHIC ESTER | THE DOW CHEMICAL COMPANY (US) | 1989-04-18 | — | — | US | claimed |
| US-4702822-A | ORGANIC SULFIDE WITH ALKYL THIOCARBONATE, THIONACARBAMATEA, OR THIOPHOSPHATE | THE DOW CHEMICAL COMPANY (US) | 1987-10-27 | — | — | US | claimed |
| US-4684459-A | Collector compositions for the froth flotation of mineral values | THE DOW CHEMICAL COMPANY (US) | 1987-08-04 | — | — | US | claimed |
| WO-1987003221-A1 | NOVEL COLLECTORS FOR FROTH FLOTATION OF MINERALS | THE DOW CHEMICAL COMPANY (US) | 1987-06-04 | — | — | WO | claimed |
| WO-1987000451-A1 | NOVEL COLLECTOR COMPOSITION FOR FROTH FLOTATION | THE DOW CHEMICAL COMPANY (US) | 1987-01-29 | — | — | WO | claimed |
| US-4354980-A | Process for producing alkyl xanthogen alkylformates | CROZIER RONALD D G | 1982-10-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149021-A1 | Piperazine mono(dithio)carbamate ester compounds and analogs thereof: preparation method and uses thereof | SIRT5, HDAC5, AADAC | CYP3A4 498/4885TSHR 2035/4885MAPT 2541/4885 |
| US-20070191288-A1 | Treatments for Benign Tumors, Cancers, Neoplasias, and/or Other Inflammatory Disorders or Diseases | TNF, GRIK5, PTGES3 | CYP3A4 1365/4885TSHR 4069/4885MAPT 568/4885 |
| US-20040191310-A1 | Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases | TNF, PTGES3, GRIK5 | CYP3A4 1325/4885TSHR 4089/4885MAPT 593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.